Most cited papers from Clinical Solutions

Clinical Solutions

What are the most cited papers from Clinical Solutions?

The most cited paper from Clinical Solutions is "Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al., 2010), with 1,038 citations. Next come "Simultaneous PET-MRI: a new approach for functional and morphological imaging" (986) and "Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial" (673).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 66 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet	30 Jul 2010	1,038
2	Simultaneous PET-MRI: a new approach for functional and morphological imaging Martin S. Judenhofer, Hans F. Wehrl, Danny F. Newport et al. · Nature Medicine	23 Mar 2008	986
3	Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial Youn H. Kim et al. · The Lancet Oncology Open access	9 Aug 2018	673
4	A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research Tanya Simuni et al. · The Lancet Neurology Open access	22 Jan 2024	626
5	Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial Thomas A. Wadden, John Paul Foreyt, Gary D. Foster et al. · Obesity Open access	17 Jun 2010	559
6	Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations Robert Randolph Edwards et al. · Pain Open access	5 May 2016	410
7	Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions Nathaniel P. Katz, Florence C. Paillard, Evan F. Ekman · Journal of Orthopaedic Surgery and Research Open access	2015	351
8	Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards Qinan Bao, Danny F. Newport, Mu Chen et al. · Journal of Nuclear Medicine Open access	17 Feb 2009	309
9	Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial James H. Lewis, Mary Ellen Mortensen, Steven Zweig et al. · Hepatology Open access	Aug 2007	309
10	Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain	9 Apr 2012	293
11	Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations Shannon M. Smith et al. · Pain ReviewOpen access	20 Jun 2013	265
12	Bridging the Digital Divide in Health Care: The Role of Health Information Technology in Addressing Racial and Ethnic Disparities Lenny López, Alexander R. Green, Aswita Tan‐McGrory et al. · The Joint Commission Journal on Quality and Patient Safety Open access	Oct 2011	198
13	Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations Shannon M. Smith et al. · Pain Open access	8 Jun 2020	197
14	Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial Xenofon Baraliakos, Laure Gossec, Effie Pournara et al. · Annals of the Rheumatic Diseases Open access	22 Dec 2020	194
15	Recommendations to improve the usability of drug-drug interaction clinical decision support alerts Thomas H. Payne et al. · Journal of the American Medical Informatics Association Open access	31 Mar 2015	193
16	Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study David Martin Simpson, Jessica Robinson‐Papp, Joanna T Van et al. · Journal of Pain Open access	16 Oct 2016	180
17	Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain Philip G. Conaghan, David John Hunter, Stanley B. Cohen et al. · Journal of Bone and Joint Surgery Open access	18 Apr 2018	176
18	PET/MR Images Acquired with a Compact MR-compatible PET Detector in a 7-T Magnet Martin S. Judenhofer, Ciprian Catana, Brian K. Swann et al. · Radiology	Sep 2007	173
19	A Study of Chief Nurse Executives Indicates Low Prioritization of Evidence-Based Practice and Shortcomings in Hospital Performance Metrics Across the United States Bernadette Mazurek Melnyk, Lynn Gallagher‐Ford, Bindu Koshy Thomas et al. · Worldviews on Evidence-Based Nursing	Feb 2016	162
20	Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study Walter Reinisch, Julián Panés, Sunil Khurana et al. · Gut	7 Jan 2015	156
21	Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial Arndt Vogel, Shukui Qin, Masatoshi Kudo et al. · The Lancet. Gastroenterology & hepatology	2 Jun 2021	155
22	Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions Nathaniel P. Katz, Richard C. Dart, Elise J. Bailey et al. · The American Journal of Drug and Alcohol Abuse	26 Apr 2011	154
23	Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age Evan J. Anderson et al. · New England Journal of Medicine Open access	19 Oct 2022	147
24	Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma Birgit Geoerger, Mark W. Kieran, Stephan A. Grupp et al. · European Journal of Cancer Open access	26 Oct 2011	145
25	Development of a Combined microPET®-MR System A.J. Lucas, Rob C. Hawkes, Richard E. Ansorge et al. · Technology in Cancer Research & Treatment Open access	Aug 2006	142
26	Validation of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Acute Low Back Pain Robert H. Dworkin, Dennis C. Turk, Jeremiah Trudeau et al. · Journal of Pain Open access	29 Jan 2015	142
27	Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study Russell Blair Egerdie, Stephen M. Auerbach, Claus G. Roehrborn et al. · The Journal of Sexual Medicine	7 Oct 2011	139
28	Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support Richard T. Scheife, Lisa E. Hines, Richard D. Boyce et al. · Drug Safety Open access	2 Jan 2015	134
29	RNA Interference With Zilebesiran for Mild to Moderate Hypertension George L. Bakris et al. · JAMA Open access1,147 authors	16 Feb 2024	129
30	The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials Tzeyu L. Michaud, Young Hee Rho, Tatyana Shamliyan et al. · The American Journal of Medicine Review	17 Jun 2014	118
31	Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy Ahmad Hussein Awada, Luc Yves Dirix, L. Manso Sanchez et al. · Annals of Oncology Open access	12 Sep 2012	117
32	Validation of the Hospital Anxiety and Depression Scale in Patients With Acute Low Back Pain Dennis C. Turk, Robert H. Dworkin, Jeremiah Trudeau et al. · Journal of Pain Open access	21 Jul 2015	116
33	Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations Jennifer S. Gewandter et al. · Pain Open access	24 May 2014	111
34	Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study John T. Farrar, Andrea B. Troxel, Kevin Haynes et al. · Pain	14 May 2014	110
35	Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table Christophe Leclercq, Henning Witt, Gerhard Hindricks et al. · EP Europace	14 Apr 2022	109
36	Effects of the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes Claire C. J. Dekkers, C. David Sjöström, Peter J. Greasley et al. · Diabetes Obesity and Metabolism Open access	13 Aug 2019	109
37	Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study Aaron I. Vinik, Serge Perrot, Etta Johanna Vinik et al. · BMC Neurology Open access	Dec 2016	108
38	Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain Panna Sanga, Nathaniel P. Katz, Elena Polverejan et al. · Pain	5 Jun 2013	107
39	Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease Claire C. J. Dekkers, David Collins. Wheeler, C. David Sjöström et al. · Nephrology Dialysis Transplantation Open access	7 Dec 2017	102
40	Measurement of quantum back action in the audio band at room temperature J. Cripe, N. Aggarwal, Robert Lanza et al. · Nature Open access	25 Mar 2019	97
41	Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database Joy Mou, Florence C. Paillard, Barry Turnbull et al. · Pain Review	21 May 2013	96
42	Towards a Competency-Based, Ethical, and Socially Valid Approach to the Supervision of Applied Behavior Analytic Trainees Laura B. Turner, Aaron J. Fischer, James K. Luiselli · Behavior Analysis in Practice Open access	28 Mar 2016	88
43	A sub-millimeter resolution PET detector module using a multi-pixel photon counter array Tae Yong Song, Heyu Wu, Sergey A. Komarov et al. · Physics in Medicine and Biology Open access	14 Apr 2010	86
44	Efficacy and safety of tanezumab in the treatment of pain from bone metastases Maciej Sopata, Nathaniel P. Katz, William Carey et al. · Pain	28 Apr 2015	85
45	Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION Robert H. Dworkin, Dennis C. Turk, Nathaniel P. Katz et al. · Pain	10 Dec 2010	84
46	A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults) Scott Donald Patterson, Chris Webber, Michael A. Patton et al. · Trials in Vaccinology Open access	2016	83
47	Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has Transcatheter Aortic Valve Replacement Made a Difference? Steven D. Culler, David Jonathan Cohen, Phillip P. Brown et al. · The Annals of Thoracic Surgery Open access	Feb 2018	82
48	Novel deep learning-based noise reduction technique for prostate magnetic resonance imaging Xinzeng Wang, Jingfei Ma, Priya Bhosale et al. · Abdominal Radiology Open access	12 Feb 2021	81
49	Composite outcomes for pain clinical trials: considerations for design and interpretation Jennifer S. Gewandter, Michael McDermott, Scott R. Evans et al. · Pain Open access	8 Jan 2021	80
50	Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations Nathaniel P. Katz et al. · Pain Open access	18 Jan 2021	77

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.